Literature DB >> 11062190

Subinhibitory concentrations of erythromycin reduce pneumococcal adherence to respiratory epithelial cells in vitro.

K Lagrou1, W E Peetermans, M Jorissen, J Verhaegen, J Van Damme, J Van Eldere.   

Abstract

We have investigated the influence of subinhibitory concentrations of erythromycin on the interaction between Streptococcus pneumoniae and human respiratory epithelial cells. Confluent in vitro cell cultures were inoculated with erythromycin-resistant S. pneumoniae and incubated for 24 h. Erythromycin significantly reduced adherence of the pneumococci after 4 h and 24 h: 4.0% +/- 0.7% (mean +/- S.E.M. ) of the pneumococci adhered to the epithelial cells in medium with erythromycin, compared with 7.7% +/- 0.8% in medium without erythromycin (P: = 0.002) after 4 h, and the corresponding values after 24 h were 24.2% +/- 5.3% and 38.4% +/- 5.0%, respectively (P: = 0.038). Disruption of epithelial integrity by S. pneumoniae, measured as the decrease in transepithelial electrical resistance, was delayed in the presence of erythromycin. Neither addition of erythromycin to the culture medium nor infection of the cell cultures with pneumococci significantly affected secretion of interleukin-8 by the epithelial cells. Addition of erythromycin to a pneumococcal suspension in cell culture medium without respiratory epithelial cells almost completely prevented the release of pneumolysin. We conclude that erythromycin at subinhibitory concentrations reduces the adherence to and disruption of respiratory epithelial cells by S. pneumoniae, possibly by interfering with pneumolysin release.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11062190     DOI: 10.1093/jac/46.5.717

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  10 in total

1.  Comparison of beta-lactam and macrolide combination therapy versus fluoroquinolone monotherapy in hospitalized Veterans Affairs patients with community-acquired pneumonia.

Authors:  Thomas P Lodise; Andrea Kwa; Leon Cosler; Reetu Gupta; Raymond P Smith
Journal:  Antimicrob Agents Chemother       Date:  2007-08-20       Impact factor: 5.191

Review 2.  Antibacterial and immunomodulatory properties of azithromycin treatment implications for periodontitis.

Authors:  P M Bartold; A H du Bois; S Gannon; D R Haynes; R S Hirsch
Journal:  Inflammopharmacology       Date:  2013-02-28       Impact factor: 4.473

3.  Virulence-suppressing effects of linezolid on methicillin-resistant Staphylococcus aureus: possible contribution to early defervescence.

Authors:  Sadako Yoshizawa; Kazuhiro Tateda; Tomoo Saga; Yoshikazu Ishii; Keizo Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  2012-01-30       Impact factor: 5.191

4.  Subinhibitory concentrations of linezolid reduce Staphylococcus aureus virulence factor expression.

Authors:  Katussevani Bernardo; Norbert Pakulat; Silke Fleer; Annabelle Schnaith; Olaf Utermöhlen; Oleg Krut; Stefan Müller; Martin Krönke
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

5.  Mechanism of Macrolide-Induced Inhibition of Pneumolysin Release Involves Impairment of Autolysin Release in Macrolide-Resistant Streptococcus pneumoniae.

Authors:  Hisanori Domon; Tomoki Maekawa; Daisuke Yonezawa; Kosuke Nagai; Masataka Oda; Katsunori Yanagihara; Yutaka Terao
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

6.  Macrolide Use and Neutrophil Function/Cytokine Levels in Hospitalized Patients with Community-Acquired Pneumonia: A Pilot Study.

Authors:  Forest W Arnold; Jose Bordon; Rafael Fernandez-Botran; Madhavi J Rane; Silvia M Uriarte; Robert Kelley; Timothy L Wiemken; Paula Peyrani; Julio A Ramirez
Journal:  Lung       Date:  2015-11-09       Impact factor: 2.584

Review 7.  Pathogen- and host-directed anti-inflammatory activities of macrolide antibiotics.

Authors:  Helen C Steel; Annette J Theron; Riana Cockeran; Ronald Anderson; Charles Feldman
Journal:  Mediators Inflamm       Date:  2012-06-21       Impact factor: 4.711

8.  Clarithromycin Inhibits Pneumolysin Production via Downregulation of ply Gene Transcription despite Autolysis Activation.

Authors:  Hisanori Domon; Toshihito Isono; Takumi Hiyoshi; Hikaru Tamura; Karin Sasagawa; Tomoki Maekawa; Satoru Hirayama; Katsunori Yanagihara; Yutaka Terao
Journal:  Microbiol Spectr       Date:  2021-09-01

Review 9.  Choosing the right combination therapy in severe community-acquired pneumonia.

Authors:  Grant W Waterer; Jordi Rello
Journal:  Crit Care       Date:  2006-02       Impact factor: 9.097

10.  [Antipseudomonic effect of macrolides. Experience in a case of nosocomial pneumonia caused by multidrug-resistant Pseudomonas aeruginosa without response to antibiotic therapy].

Authors:  J M Barbero; A Arranz; A Rebollar; A Culebras; M García; R Agudo; L Pérez; E Montero
Journal:  Rev Esp Quimioter       Date:  2018-01-31       Impact factor: 1.553

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.